CAPITAL ACCESS AGREEMENTCapital Access Agreement • April 20th, 2016 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CAPITAL ACCESS AGREEMENT (the “Agreement”), is dated as of April 19, 2016, by and between Immune Pharmaceuticals Inc., a Delaware corporation, (the “Company”), and Regatta Select Healthcare, LLC, a Delaware limited liability company (including any designee(s) thereof, the “Investor”).
